Richard W Pascoe insider trades: Zevra Therapeutics (ZVRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
and 1 more company
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | ZVRA | ↑ Buy | 10,000 | $4.20 | $42K | Direct | Mar 13, 2023 (4d) |
| Jan 13, 2023 | KMPH | ↑ Buy | 9,500 | $5.44 | $52K | Direct | Jan 13, 2023 (0d) |
| May 18, 2022 | KMPH | ↑ Buy | 5,000 | $4.92 | $25K | Direct | May 18, 2022 (0d) |
| Nov 30, 2021 | KMPH | ↑ Buy | 1,500 | $7.88 | $12K | Direct | Nov 30, 2021 (0d) |
| Mar 30, 2021 | HSTO | ↑ Buy | 20,000 | $1.14 | $23K | Direct | Mar 30, 2021 (0d) |
| Dec 3, 2020 | HSTO | ↑ Buy | 10,000 | $1.24 | $12K | Direct | Dec 7, 2020 (4d) |
| Aug 18, 2020 | KMPH | ↑ Buy | 10,000 | $0.64 | $6K | Direct | Aug 18, 2020 (0d) |
| Dec 22, 2014 | APRI | ↑ Buy | 10,000 | $1.02 | $10K | Direct | Dec 22, 2014 (0d) |
| Oct 22, 2014 | APRI | ↑ Buy | 12,000 | $1.51 | $18K | Direct | Oct 24, 2014 (2d) |
| May 23, 2013 | APRI | ↑ Buy | 35,000 | $2.85 | $100K | Direct | May 24, 2013 (1d) |
| Jan 3, 2012 | SOMX | ↓ Sell | 18,750 | $0.48 | $9K | Direct | Jan 4, 2012 (1d) |
| Jun 10, 2011 | SOMX | ↑ Buy | 11,100 | $2.25 | $25K | Direct | Jun 13, 2011 (3d) |
| Dec 1, 2010 | SOMX | ↓ Sell | 13,781 | $2.68 | $37K | Direct | Dec 3, 2010 (2d) |
| Mar 18, 2010 | SOMX | ↓ Sell | 104,510 | $5.99 | $626K | Direct | Mar 19, 2010 (1d) |
| Mar 1, 2010 | SOMX | ↓ Sell | 40,000 | $4.01 | $161K | Direct | Mar 3, 2010 (2d) |
| Feb 5, 2010 | SOMX | ↓ Sell | 62,000 | $3.03 | $188K | Direct | Feb 9, 2010 (4d) |
| Dec 31, 2009 | SOMX | ↓ Sell | 8,000 | $1.07 | $9K | Direct | Jan 5, 2010 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ZVRA insiders
Open-market trades in the last 12 months
About Richard W Pascoe's insider trades
Richard W Pascoe is Chief Executive Officer at Zevra Therapeutics (ZVRA). Since Dec 31, 2009, Richard has reported 11 open-market purchases worth $325K and 6 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (42 filings), shares withheld for taxes (5 filings), option exercises (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZVRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.